Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07224035 · ClinicalTrials.gov registry record · Phase 4

Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1

A Phase 4 study of Gastric Cancer and H. Pylori Infection, sponsored by University of Miami.

Active
Registry status
Phase 4
Development phase
500
Enrollment target
1
Study location

NCT07224035 is a Phase 4 study of Gastric Cancer and H. Pylori Infection that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 500 participants, above the 316-participant average among 153 other Gastric Cancer trials with a reported enrollment target (58% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07224035, a Phase 4 study of Gastric Cancer and H. Pylori Infection, is active but no longer recruiting, sponsored by University of Miami.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

H. pylori is an infection of the stomach that can cause chronic gastritis, gastric cancer and peptic ulcer disease. The goal of this study is to screen people for this infection and offer treatment for those who test positive for the infection. By treating those who are positive for H. pylori, there is an opportunity to prevent gastritis, peptic ulcer disease, and even gastric cancer.

Conditions Studied

Gastric Cancer H. Pylori Infection H Pylori Gastritis

Interventions

  • DRUG PYTEST® 14C-Urea Breath Test
  • DRUG VOQUEZNA® Triple Pak®

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2022-10-15
Est. Completion 2027-11-06
Phase Phase 4

Sponsor

University of Miami

721 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07224035

The ClinicalTrials.gov registry entry for NCT07224035 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 316-participant average among 153 other Gastric Cancer trials with a reported enrollment target (58% higher). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Gastric Cancer appearing as the primary indexed condition, and to 2 interventions - of which PYTEST® 14C-Urea Breath Test is the first listed.

NCT07224035 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT07224035 about?

NCT07224035 is a clinical study titled "Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1". H. pylori is an infection of the stomach that can cause chronic gastritis, gastric cancer and peptic ulcer disease. The goal of this study is to screen people for this infection and offer treatment for those who test positive for the infection. By treating those who are positive for H. pylori, there...

What is the current status of trial NCT07224035?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 500 participants. The study started on 2022-10-15. Estimated completion is 2027-11-06.

What conditions does trial NCT07224035 study?

This clinical trial studies the following conditions: Gastric Cancer, H. Pylori Infection, H Pylori Gastritis.

What interventions are being tested in trial NCT07224035?

The interventions under investigation include: PYTEST® 14C-Urea Breath Test (DRUG), VOQUEZNA® Triple Pak® (DRUG).

Who is sponsoring clinical trial NCT07224035?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07224035 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Gastric Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Gastric Cancer

All registered trials for this condition

H. Pylori Infection

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.